Stifel Nicolaus Boosts Adient (NYSE:ADNT) Price Target to $26.00

Adient (NYSE:ADNT) had its price target raised by investment analysts at Stifel Nicolaus from $24.00 to $26.00 in a research report issued on Friday, Marketbeat.com reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price target would indicate a potential upside of 19.54% from the company’s previous close.

ADNT has been the topic of a number of other research reports. Wall Street Zen cut Adient from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Barclays boosted their price target on Adient from $24.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Friday. UBS Group set a $30.00 price objective on shares of Adient and gave the company a “buy” rating in a research note on Wednesday, January 14th. Weiss Ratings reissued a “sell (d)” rating on shares of Adient in a research report on Wednesday. Finally, Morgan Stanley raised shares of Adient from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $17.00 to $20.00 in a report on Monday, December 8th. Three research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $24.56.

Adient Trading Down 0.5%

Shares of NYSE ADNT traded down $0.10 during trading on Friday, hitting $21.75. 149,517 shares of the company traded hands, compared to its average volume of 1,374,021. The company has a quick ratio of 0.93, a current ratio of 1.12 and a debt-to-equity ratio of 1.16. Adient has a 1 year low of $10.04 and a 1 year high of $26.16. The firm has a market capitalization of $1.72 billion, a P/E ratio of -6.52, a P/E/G ratio of 0.74 and a beta of 1.61. The company has a 50-day moving average price of $19.74 and a 200-day moving average price of $22.05.

Adient (NYSE:ADNT) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.52 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.03). Adient had a negative net margin of 1.93% and a positive return on equity of 7.81%. The business had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.58 billion. During the same period last year, the firm earned $0.68 earnings per share. The company’s quarterly revenue was up 3.5% on a year-over-year basis. On average, equities analysts predict that Adient will post 1.76 EPS for the current year.

Insider Buying and Selling

In related news, EVP Michel Pierre Rose Berthelin sold 2,500 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $19.71, for a total transaction of $49,275.00. Following the completion of the sale, the executive vice president directly owned 116,425 shares of the company’s stock, valued at $2,294,736.75. This trade represents a 2.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.72% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Adient

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ADNT. Royal Bank of Canada increased its position in Adient by 11.6% during the first quarter. Royal Bank of Canada now owns 22,429 shares of the company’s stock worth $289,000 after buying an additional 2,331 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Adient by 171.1% in the 1st quarter. AQR Capital Management LLC now owns 238,913 shares of the company’s stock valued at $2,977,000 after purchasing an additional 150,792 shares during the period. Dynamic Technology Lab Private Ltd bought a new position in Adient during the 1st quarter worth $236,000. Parallel Advisors LLC boosted its position in shares of Adient by 13,957.9% during the 2nd quarter. Parallel Advisors LLC now owns 2,671 shares of the company’s stock worth $52,000 after acquiring an additional 2,652 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC acquired a new position in Adient during the second quarter worth about $661,000. Institutional investors own 92.44% of the company’s stock.

Adient Company Profile

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.